Abstract
Two unrelated patients with cryptic subtelomeric deletions of 22q13.3 were identified using FISH with the commercially available Oncor probe, D22S39. Proband 1 was found to have a derivative chromosome 22 resulting from the unbalanced segregation of a t(l;22)(q44;q13.32) in her mother. Additional FISH analysis of proband 1 and her mother placed the breakpoint on chromosome 22 in this family proximal to D22S55 and D22S39 and distal to D22S45. We have mapped D22S39 to within 170 kb of D22S21 using pulsed field gel electrophoresis. D22S21 is genetically mapped between D22S55 and D22S45. These data indicate that the deletion in proband 1 is smaller than in eight of nine reported del(22)(ql3.3) patients. Probands 1 and 2 share features of hypotonia, developmental delay, and expressive language delay, also seen in previously reported del(22) (ql3.3) patients, although proband 1 appears to be more mildly affected. Proband 1 is also trisomic for the region 1q44--qter. This very small duplication has been previously reported only once and the patient had idiopathic mental retardation. This is the first report where 22ql3.3 terminal deletion patients have been identified through the use of FISH, and the first report of a deletion of this region occurring because of missegregation of a parental balanced cryptic translocation. We feel that investigation ofthe frequency ofdel (22) Pulsed field gel electrophoresis (PFGE) was performed using a CHEF-DRII apparatus (BioRad). Cells from three subjects normal for the 22ql3.3 region were embedded in agarose and processed as previously described.8 DNA was digested with NotI, NruI, AscI, or BszWI and separated by PFGE at 150 V using a 120 second switch time for 22 hours followed by a 180 second switch time for 22 hours. The resulting blot was probed with the clone for D22S21. The blot was then stripped of signal and reprobed with the clone for D22S39. 3A) . The parents of proband 2 are unavailable for study. FISH analysis was performed with chromosome 22q terminal YAC probes. Hybridisation with either YAC 412H3 (which contains the DNA marker D22S55) or YAC 120E4 (encompassing D22S45) resulted in a fluorescent signal on only one chromosome 22qter in metaphase spreads from proband 2 (data not shown). Thus the breakpoint in this subject is located proximal to both of these loci.
MAPPING OF D22S39
D22S39 (H17) has been placed into the last somatic cell hybrid panel "bin" of chromosome 22 (bin22).9 Using pulsed field gel electrophoresis we further localised this marker to not more than 170 kb from the probe for D22S21 (W13E) (fig 2G) . Digestion of normal DNA with NotI, NruI, AscI, and BszWI gave identical bands when probed with clones for D22S39 or D22S21 (data not shown). The smallest band detected by both probes was 170 kb (NruI digest). D22S21 has been genetically mapped between D22S45 and D22S55'0 ( fig 2G) .
FISH ANALYSIS OF A PREVIOUSLY REPORTED DEL(22)(q13.3) PATIENT USING D22S39
As further evidence for the value of D22S39 in FISH analysis to detect 22qter deletion patients, we assayed metaphase spreads from FB, a previously described de novo del(22)(q13.31) patient, and his parents," and verified that only one distal 22q hybridisation signal was seen in FB and two signals were seen in both of his parents (data not shown). The breakpoint in this patient had been previously localised using dosage and RFLP analysis between D22S64 and D22S952 ( fig 2G) .
Discussion
The clinical features in these two probands with monosomy for 22ql3.32-22qter are similar to those described in previously reported cases of 22q13.3 deletions'-3 (table 1) . Proband 1 appears to be more mildly affected in that she walked earlier (16 months), speaks a few words, and does not have any dysmorphic features other than epicanthic folds (table 1) . This would seem to correlate with the fact that her breakpoint is located between D22S45 and D22S39, distal to the breakpoints defined for the patients described in Nesslinger et af ( fig  2C) . Enzyme studies measuring arylsulphatase A (ARSA) activities in proband 1 and her parents were consistent with deletion of this locus in proband 1 (data not shown). A pulse field gel electrophoresis map of 22q13.3 (H McDermid, unpublished data) gives a rough estimate (a gap exists between H91 and ARSA which cannot be measured) of a distance of over 1800 kb from D22S39/D22S21 to the telomere. The only reported 22qter deletion patient (NT) with a smaller deletion than proband 1 is reported to be non-dysmorphic with normal motor milestones, mild mental retardation, and first words at the age of 4 years.' His deletion has been reported to be approximately 120 kb in size, with the breakpoint located distal to ARSA.'2 1 ' Proband 1, in addition to monosomy for 22ql3.32--22qter is trisomic for the region 1 q44--1 qter. A review of published reports identified only one previous report of dup(l)(q44) in which the proband had idiopathic mental retardation with no associated malformations.'4 A review of patients carrying a duplication of the distal third of chromosome 1 (breakpoints from q23-q44) showed no features in common with proband 1 other than developmental delay. '5 Proband 2 is still too young to ascertain the degree of severity of her language and motor delay. The general clinical impression of her progress indicates that she is more severely affected than proband 1, as would be expected from the result that her chromosome 22 
